Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 118
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01359956 | Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma | ||
| NCT00331097 | ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment | ||
| NCT05817227 | Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer. | ||
| NCT02786875 | Diet, Exercise and Vitamin D in Breast Cancer Recurrence | ||
| NCT01755182 | Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors | ||
| NCT05733806 | Study on Gynecological Rare Cancers | ||
| NCT01074684 | Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer | ||
| NCT00540800 | BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer | ||
| NCT04854213 | PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells) | ||
| NCT04129281 | Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma | ||
| NCT00996983 | Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer | ||
| NCT00403429 | MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer | ||
| NCT00401635 | END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin | ||
| NCT02619435 | Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer | ||
| NCT01651013 | Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras | ||
| NCT06270602 | The ONCOCAMP Study | ||
| NCT01651026 | Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer | ||
| NCT04425239 | Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer | ||
| NCT07290894 | Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01 | ||
| NCT00401492 | MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer | ||
| NCT04071704 | Assessing Health-related Quality of Life in Sarcoma Patients | ||
| NCT06714357 | ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer | ||
| NCT04290299 | Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive | ||
| NCT03975114 | A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5) | ||
| NCT06887244 | Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial Toxicity | ||
| NCT04122911 | Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas | ||
| NCT01644825 | Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer | ||
| NCT02069067 | Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated | ||
| NCT04310176 | Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer | ||
| NCT03203005 | IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients | ||
| NCT00415779 | ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer | ||
| NCT01706120 | Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab | ||
| NCT07027046 | Application of da Vinci SP for Endometrial Cancer Surgical Staging | ||
| NCT00326456 | MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer | ||
| NCT04416672 | Validation of the Italian Version of the PRO-CTCAE | ||
| NCT04397601 | Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer | ||
| NCT04123925 | Preoperative Nivolumab in Patients With Locally Advanced Colon Cancer (T3 or T4): a Window-of-opportunity Study | ||
| NCT01718873 | Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer | ||
| NCT03380858 | REINFORCEMENT ANASTOMOSIS WITH Modified Cyanacrylate IN Patients Undergoing to Oncologic Colorectal Surgery With Colorectal Anastomosis | ||
| NCT02633189 | Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer | ||
| NCT05806151 | Prediction of True Oligo-metastatic Disease. | ||
| NCT06866093 | The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical. | ||
| NCT05733793 | Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients. | ||
| NCT00431704 | VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer | ||
| NCT01898104 | Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer | ||
| NCT02364791 | A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures | ||
| NCT03473379 | Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity in Italy | ||
| NCT06218511 | A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1) | ||
| NCT03891485 | Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy | ||
| NCT00401674 | MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer |
